He is taking his new show across the country
Professor Brian Cox is coming back to Northern Ireland after announcing a number of tour dates across the country next year.
He will take the dazzling show to Belfast, Derry, Armagh and Coleraine in January 2024, with tickets going on sale from Ticketmaster.ie on Friday, May 12 at 10am.Horizons has taken over 250,000 people across three continents on a dazzling journey; a story of how we came to be and what we can become. What is the nature of space and time? How did life begin, how rare might it be and what is the significance of life in the Cosmos? What does it mean to live a small, finite life in a vast, eternal Universe?
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Farewell to councillor who played key part in Lancaster's finances through CovidAnne Whitehead, who is a retired Lancaster University professor, said difficult decisions had to be made during her time, with the last year being 'demanding and stressful'
Read more »
Miriam Margolyes sparks concern as she's rushed to A&E and shares hospital snapHarry Potter star Miriam Margolyes – who plays Professor Pomona Sprout in the wizarding franchise – was taken to Royal Brompton and Harefield Hospital with a chest infection
Read more »
After 4 People Shot at Multiple Scenes in Boston, Police Plead for Public's HelpPolice in Boston are investigating after a violent night in the city on Sunday, when two people were killed and another two were wounded during multiple shootings, according to police. “Tonight we’ve had a pretty violent night in the city,” Boston Police Commissioner Michael Cox said during a news conference Sunday. “We do ask for the public’s help for this.”…
Read more »
Harry Potter star rushed to A&E as she updates fans with pic from hospital bedHARRY Potter star Miriam Margolyes revealed she’s been rushed to A&E as she updated fans from her hospital bed. The actress – who played Professor Pomona Sprout in the wizarding fra…
Read more »
Timing of intubation and ICU mortality in COVID-19 patients: a retrospective analysis of 4198 critically ill patients during the first and second waves - BMC AnesthesiologyBackground The optimal time to intubate patients with SARS-CoV-2 pneumonia has not been adequately determined. While the use of non-invasive respiratory support before invasive mechanical ventilation might cause patient-self-induced lung injury and worsen the prognosis, non-invasive ventilation (NIV) is frequently used to avoid intubation of patients with acute respiratory failure (ARF). We hypothesized that delayed intubation is associated with a high risk of mortality in COVID-19 patients. Methods This is a secondary analysis of prospectively collected data from adult patients with ARF due to COVID-19 admitted to 73 intensive care units (ICUs) between February 2020 and March 2021. Intubation was classified according to the timing of intubation. To assess the relationship between early versus late intubation and mortality, we excluded patients with ICU length of stay (LOS) | 7 days to avoid the immortal time bias and we did a propensity score and a cox regression analysis. Results We included 4,198 patients [median age, 63 (54‒71) years; 71% male; median SOFA (Sequential Organ Failure Assessment) score, 4 (3‒7); median APACHE (Acute Physiology and Chronic Health Evaluation) score, 13 (10‒18)], and median PaO2/FiO2 (arterial oxygen pressure/ inspired oxygen fraction), 131 (100‒190)]; intubation was considered very early in 2024 (48%) patients, early in 928 (22%), and late in 441 (10%). ICU mortality was 30% and median ICU stay was 14 (7‒28) days. Mortality was higher in the “late group” than in the “early group” (37 vs. 32%, p | 0.05). The implementation of an early intubation approach was found to be an independent protective risk factor for mortality (HR 0.6; 95%CI 0.5‒0.7). Conclusions Early intubation within the first 24 h of ICU admission in patients with COVID-19 pneumonia was found to be an independent protective risk factor of mortality. Trial registration The study was registered at Clinical-Trials.gov (NCT04948242) (01/07/2021).
Read more »